FilingSEC EDGAR8-K
BioRestorative Therapies Faces Resignation and Severance Dispute with R&D VP
· SEC accepted
StageExecutive Resignation
Filing content
The company's R&D VP resigned claiming severance, but the company is investigating the validity of the employment agreement and has withheld payments.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…